Filing metadata

Accession number
0000947871-24-000501
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
May 20, 2024
Reporting period
May 16, 2024
Description
Insider transaction

Explore SEC Filings Hub